PSI Establishes Strategic Network of Leading Taiwan Medical Centers to Accelerate Study Startup and Enrollment
Atossa Therapeutics Selects PSI as Contract Research Organization for Pivotal Dose-Ranging Study of (Z)-Endoxifen in Metastatic Breast Cancer
